Pharmafile Logo

Peter Impey

- PMLiVE

New technology can unlock revenue opportunities for pharma brands

Keep engaged with customers as new touchpoints emerge

- PMLiVE

Novartis appoints new comms chief

Michael Willi replaces Michele Galen

- PMLiVE

Hill+Knowlton Strategies creates EMEA division

Will be led by European president Lars Erik Grønntun

- PMLiVE

Novartis, Boehringer stake claims to combination COPD market

Includes combination follow-up to Spiriva

Roche - Basel

Roche and Merck boost manufacturing capacity

Pharma companies invest in European facilities

- PMLiVE

Gilead’s RSV drug clears mid-stage trial

Late-stage data demonstrates GS-5806 is effective in treating the infection

- PMLiVE

No mass revolt from AZ shareholders on Pfizer takeover

Company’s decision to stand firm is applauded by investors

- PMLiVE

Epilepsy takes centre stage in UK

National Epilepsy Week aims to raise awareness of the neurological condition

- PMLiVE

PAN strengthens its team

Creative agency announces two new arrivals and three promotions

- PMLiVE

Nothing makes sense

Evolutionary theory helps us understand and adapt to the current deal-making frenzy

- PMLiVE

Cello Group buys iS Healthcare Dynamics

Marketing firm could pay more than £5m for Surrey agency

- PMLiVE

FDA clears Takeda’s vedolizumab for inflammatory bowel disease

Entyvio licensed for patients who have not responded to current therapies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links